Deck 12: Mens Health

Question 1

A patient being treated for erectile dysfunction is prescribed sildenafil 50 mg PRN. Which assessment finding would be most concerning to the provider?

A) Current blood pressure reading of 118/76
B) Patient notes erection lasting at least 3 hours
C) Patient reports onset of blurred vision
D) New onset of snoring that wakens the patient's partner

Answer 1

New onset of snoring that wakens the patient's partner

Question 2

A prescriber is providing education to a patient who is beginning therapy with testosterone gel. Which statement made by the patient demonstrates a need for further teaching?

A) "This drug puts me at an increased risk for blood clots."
B) "I will need to tell my pregnant wife not to handle my laundry."
C) "I should have my blood drawn for laboratory tests in 14 days."
D) "I should apply the medication to my genitals for best results."

Answer 2

"I should apply the medication to my genitals for best results."

Question 3

A prescriber is teaching a male adult patient about the use of testosterone gel. Which statement by the patient indicates an understanding of the teaching?

A) "I should apply this to my forearms and neck after showering."
B) "I should keep treated areas exposed to the air so that they can dry."
C) "I should wash the application site before being intimate with my partner."
D) "I should not swim or bathe for 3 to 4 hours after applying the gel."

Answer 3

"I should wash the application site before being intimate with my partner."

Question 4

An adult patient anemia following cancer chemotherapy will now begin treatment with testosterone. Which statement by the patient indicates understanding of the provider's teaching?

A) "Facial hair may develop with this drug but will go away over time."
B) "I may experience an increase in breast size while taking this drug."
C) "Testosterone may increase my high-density lipoprotein (HDL) cholesterol and reduce my low-density lipoprotein (LDL) cholesterol."
D) "Testosterone treats anemia by stimulating the synthesis of a renal hormone."

Question 5

A provider assesses an adolescent male patient who has been receiving androgen therapy for hypogonadism via a transdermal patch. The patient's last clinic visit was 4 weeks earlier. Which part of the interval history is of greatest concern to the provider?

A) Five-pound weight gain
B) Increased growth of pubic hair
C) Rash at the site of the patch
D) Presence of acne

Question 6

An adult male patient will begin androgen therapy for testicular failure. Which statement by the patient indicates understanding of the treatment regimen as provided by the prescriber?

A) "I will need to periodic x-rays."
B) "My libido may improve."
C) "This may decrease my hair loss."
D) "This will restore fertility."

Question 7

A 14-year-old male patient is admitted to the hospital following a football injury. The patient is muscular, has a deep voice, and full beard. Which tests will the provider order in response to these assessment findings? (Select all that apply.)

A) Thyroid-stimulating hormone (TSH) level
B) Complete blood count (CBC) with differential
C) Liver function tests
D) Serum glucose and hemoglobin A_1c
E) Serum cholesterol

Question 8

After being educated about administration of papaverine plus phentolamine for erectile dysfunction, which statement made by the patient indicates a need for further teaching by the prescriber?

A) "I can expect rapid onset of an erection."
B) "I will take the pill 30 minutes before sex."
C) "I should get up from my seat slowly when taking this."
D) "I will notify the provider if I feel hard areas on my penis."

Question 9

A patient prescribed dutasteride 2 weeks ago reports continued urinary hesitancy. Which action by a provider is most appropriate?

A) Obtaining a urine sample
B) Doubling the daily dose
C) Performing a prostate examination
D) Documenting these findings

Question 10

A 14-year-old male patient diagnosed with hypogonadism will begin testosterone patch therapy. What information will the prescriber include when teaching the family about this therapy?

A) Annual x-rays of the hands and wrists are necessary to monitor epiphyseal closure.
B) Gynecomastia may occur and is a common side effect.
C) The patch is applied once daily to the back or abdomen.
D) Use of this drug may lead to prostate cancer later in life.

Question 11

A 14-year-old male patient who has not yet begun puberty reports being bullied at school. The boy's father reports that he and his father also experienced teasing as adolescents because they did not begin puberty until around age 16 years. What will the provider tell the patient and his father when they ask what can be done?

A) "A limited course of androgen therapy may be prescribed, but it is not necessary."
B) "He will eventually begin puberty, so this is nothing to worry about."
C) "There is nothing that can be done about the puberty delay, but I can make a referral for psychological counseling."
D) "The risk of accelerated growth plate closure is too great to warrant androgen therapy."

Question 12

A patient receiving intracavernousal alprostadil discusses switching to the transurethral administration route. Which information does the provider include as a benefit of changing administration routes?

A) Transurethral administration has fewer side effects.
B) Transurethral administration helps increase arterial flow to the penis.
C) Erection develops in about 30 minutes and lasts up to 2 hours with transurethral administration.
D) The required dose is much smaller with transurethral administration.

Question 13

A patient receiving doxazosin presents for a routine evaluation. Which assessment finding related to the medication therapy would be most concerning to the provider?

A) Blood pressure 96/58
B) Dizziness when standing
C) Increased nasal congestion
D) Diminished ejaculate volume

Question 14

Which finding indicates that terazosin has been effective for a patient with benign prostatic hypertrophy (BPH)?

A) Decreased prostate size
B) Increased urinary frequency
C) Decreased urinary hesitation
D) Decreased serum PSA levels